SDHD Antibodies

Santa Cruz Biotechnology features a diverse variety of SDHD monoclonal antibodies for investigating the succinate dehydrogenase complex and its role in cellular metabolism. SDHD monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Succinate dehydrogenase (SDH) is a crucial enzyme in the tricarboxylic acid (TCA) cycle, linking the metabolic pathways of respiration and energy production. The SDHD subunit plays a vital role in the assembly and stability of the SDH complex, influencing cellular energy homeostasis and signaling pathways. Dysregulation of SDHD has been implicated in various pathologies, including certain types of cancer and mitochondrial disorders, making it a significant target for research. Understanding SDHD function is essential for developing new therapeutic strategies for metabolic diseases. Researchers can utilize SDHD monoclonal antibodies to explore the complex interactions between mitochondrial function and cellular health. SDHD investigation continues to reveal new insights into energy metabolism and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of cellular metabolism and its impact on human health.